First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain
Abroad (travel likely)CompletedEARLY_PHASE1
Conditions
Progressive Supranuclear Palsy (PSP) · Healthy Participants
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Invicro (dba Perceptive), New Haven, Connecticut, United States
View source on ClinicalTrials.gov(opens in a new tab)
No study contact email or phone is listed for this trial.